Libman E, Lemberger J, Kollin J
Acta Hepatogastroenterol (Stuttg). 1979 Jun;26(3):198-202.
The authors presented a patient with primary gastric cancer and liver metastases. They permanently observed the AFP concentrations before, during and after cytostatic therapy. At the same time they examined possible sites of AFP production. It is supposed that AFP neo-synthesis takes place in the secondary site with participation of altered liver cells. In such cases it is important to watch the AFP values, and this is also necessary when the primary source of the secondary liver cancer is not known. Cytostatic drugs act only in a palliative way i.e. AFP concentrations drop to a lower level and the patient feels temporarily better.
作者报告了一名患有原发性胃癌并伴有肝转移的患者。他们持续观察了细胞抑制疗法前、治疗期间及治疗后的甲胎蛋白(AFP)浓度。同时,他们检查了AFP可能的产生部位。据推测,AFP的重新合成发生在继发部位,有发生改变的肝细胞参与其中。在这种情况下,监测AFP值很重要,当继发性肝癌的原发部位不明时,这也是必要的。细胞抑制药物仅起到姑息性作用,即AFP浓度降至较低水平,患者暂时感觉好转。